NCT01008345View on ClinicalTrials.gov

Effect of Ezetimibe on Oxidized Low-density Lipoprotein (LDL) Cholesterol

PHASE4CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions

Coronary Artery DiseaseDiabetes

Interventions

DRUG

ezetimibe

Patients will receive 10 mg/day of ezetimibe for 8 weeks

Trial Locations (1)

0000

Hotel Dieu de France Hospital, El Achrafiyé

Sponsors

Collaborators (1)

Pharmaline, Lebanon

All Listed Sponsors

collaborator

Pharmaline, Lebanon

UNKNOWN

lead

Hotel Dieu de France Hospital

OTHER